Nonstructural protein 5A/P32 deletion after failure of ledipasvir/sofosbuvir in hepatitis C virus genotype 1b infection

被引：17

作者：

Doi, Akira ^{[1
]}

Hikita, Hayato ^{[1
]}

Sakamori, Ryotaro ^{[1
]}

Tahata, Yuki ^{[1
]}

Kai, Yugo ^{[1
]}

Yamada, Ryoko ^{[1
]}

Yakushijin, Takayuki ^{[2
]}

Mita, Eiji ^{[3
]}

Ohkawa, Kazuyoshi ^{[4
]}

Imai, Yasuharu ^{[5
]}

Furuta, Kunimaro ^{[1
]}

Kodama, Takahiro ^{[1
]}

Tatsumi, Tomohide ^{[1
]}

Takehara, Tetsuo ^{[1
]}

机构：

[1] Osaka Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan

[2] Osaka Gen Med Ctr, Dept Gastroenterol & Hepatol, Osaka, Japan

[3] Osaka Natl Hosp, Natl Hosp Org, Dept Gastroenterol & Hepatol, Osaka, Japan

[4] Osaka Int Canc Inst, Dept Hepatobiliary & Pancreat Oncol, Osaka, Japan

[5] Ikeda Municipal Hosp, Ikeda, Osaka, Japan

来源：

HEPATOLOGY | 2018年 / 68卷 / 01期

关键词：

D O I：

10.1002/hep.29836

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：380 / 383

页数：4

共 4 条

[1] Ledipasvir plus sofosbuvir as salvage therapy for HCV genotype 1 failures to prior NS5A inhibitors regimens [J].

Akuta, Norio ;

Sezaki, Hitomi ;

Suzuki, Fumitaka ;

Fujiyama, Shunichiro ;

Kawamura, Yusuke ;

Hosaka, Tetsuya ;

Kobayashi, Masahiro ;

Kobayashi, Mariko ;

Saitoh, Satoshi ;

Suzuki, Yoshiyuki ;

Arase, Yasuji ;

Ikeda, Kenji ;

Kumada, Hiromitsu .

JOURNAL OF MEDICAL VIROLOGY, 2017, 89 (07) :1248-1254

[2] Baseline quasispecies selection and novel mutations contribute to emerging resistance-associated substitutions in hepatitis C virus after direct-acting antiviral treatment [J].

Kai, Yugo ;

Hikita, Hayato ;

Morishita, Naoki ;

Murai, Kazuhiro ;

Nakabori, Tasuku ;

Iio, Sadaharu ;

Hagiwara, Hideki ;

Imai, Yasuharu ;

Tamura, Shinji ;

Tsutsui, Syusaku ;

Naito, Masafumi ;

Nishiuchi, Meiko ;

Kondo, Yasuteru ;

Kato, Takanobu ;

Suemizu, Hiroshi ;

Yamada, Ryoko ;

Oze, Tsugiko ;

Yakushijin, Takayuki ;

Hiramatsu, Naoki ;

Sakamori, Ryotaro ;

Tatsumi, Tomohide ;

Takehara, Tetsuo .

SCIENTIFIC REPORTS, 2017, 7

[3] Persistence of Resistant Variants in Hepatitis C Virus-Infected Patients Treated with the NS5A Replication Complex Inhibitor Daclatasvir [J].

Wang, Chunfu ;

Sun, Jin-Hua ;

O'Boyle, Donald R., II ;

Nower, Peter ;

Valera, Lourdes ;

Roberts, Susan ;

Fridell, Robert A. ;

Gao, Min .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (05) :2054-2065

[4] Post-treatment resistance analysis of hepatitis C virus from phase II and III clinical trials of ledipasvir/sofosbuvir [J].

Wyles, David ;

Dvory-Sobol, Hadas ;

Svarovskaia, Evguenia S. ;

Doehle, Brian P. ;

Martin, Ross ;

Afdhal, Nezam H. ;

Kowdley, Kris V. ;

Lawitz, Eric ;

Brainard, Diana M. ;

Miller, Michael D. ;

Mo, Hongmei ;

Gane, Edward J. .

JOURNAL OF HEPATOLOGY, 2017, 66 (04) :703-710

← 1 →